Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner acquired 39,500,000 shares of the firm’s stock in a transaction on Wednesday, February 26th. The shares were bought at an average price of A$0.01 ($0.01) per share, for a total transaction of A$474,000.00 ($300,000.00).
James Garner also recently made the following trade(s):
- On Tuesday, December 24th, James Garner acquired 1,500,000 shares of Percheron Therapeutics stock. The shares were purchased at an average cost of A$0.01 ($0.00) per share, with a total value of A$10,500.00 ($6,645.57).
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Read More
- Five stocks we like better than Percheron Therapeutics
- Do ETFs Pay Dividends? What You Need to Know
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Why Are These Companies Considered Blue Chips?
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
- What is a Stock Market Index and How Do You Use Them?
- Will Alibaba’s $53B AI Bet Be the Key to Tech Supremacy?
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
